The organisation has its headquarters in Paris, France, with regional offices all over the world, including the West African Regional Office (BRAO) in Lomé, Togo.

Berlin: Bayer has submitted an application to the European Medicines Agency (EMA) seeking approval of aflibercept 8 mg (114.3 mg/ml solution for injection) for the treatment of patients with macular ...

Bayer seeks EMA approval to expand aflibercept 8 mg use for macular edema post retinal vein occlusion. Phase 3 QUASAR study data showed aflibercept 8 mg improved BCVA in patients with RVO, supporting ...

A retinal artery occlusion (RAO) is also called an eye stroke. It's a blockage in one or more arteries of the retina. An eye stroke is caused by a clot or cholesterol build-up in an artery. There two ...

Objective: This study aims to identify factors influencing successful recanalization following endovascular intervention for non-acute basilar artery occlusion (NABAO). Background: Endovascular ...

Background: Internal carotid artery occlusion (ICAO) is a relatively uncommon but important cause of transient ischemic attack and cerebral infarction. The majority of cases of symptomatic ICAO ...

The following is a summary of “National Trends in Central Retinal Artery Occlusion Presentations and Stroke Workup in United States Emergency Department,” published in the March 2025 issue of American ...

What started as a tragedy, turned into advocacy work for one South Carolina woman. Cheryl Lavallee, 65, and her family have lived in Waterloo for the last nine years. The family moved to South ...

Clinical variables associated with these neurological complications include age, prior cerebrovascular or peripheral arterial disease, congestive heart failure, and CPB duration of more than 2 hours.